Report Detail
Global Pharmaceutical Excipient Albumin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4744622 |
- 28 September, 2026 |
- Global |
- 123 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Pharmaceutical Excipient Albumin market size was valued at US$ 928 million in 2025 and is forecast to a readjusted size of US$ 1563 million by 2032 with a CAGR of 7.8% during review period.
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Pharmaceutical Excipient Albumin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pharmaceutical Excipient Albumin market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pharmaceutical Excipient Albumin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pharmaceutical Excipient Albumin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pharmaceutical Excipient Albumin market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Excipient Albumin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Excipient Albumin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion, LFB Group, Albumedix, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pharmaceutical Excipient Albumin market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Human Serum Albumin
Recombinant Albumin
Market segment by Application
Cell Culture Media
Medical Supplements
Major players covered
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Excipient Albumin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharmaceutical Excipient Albumin, with price, sales quantity, revenue, and global market share of Pharmaceutical Excipient Albumin from 2021 to 2026.
Chapter 3, the Pharmaceutical Excipient Albumin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Excipient Albumin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pharmaceutical Excipient Albumin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical Excipient Albumin.
Chapter 14 and 15, to describe Pharmaceutical Excipient Albumin sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Pharmaceutical Excipient Albumin Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Human Serum Albumin
- 1.3.3 Recombinant Albumin
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Pharmaceutical Excipient Albumin Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Cell Culture Media
- 1.4.3 Medical Supplements
- 1.5 Global Pharmaceutical Excipient Albumin Market Size & Forecast
- 1.5.1 Global Pharmaceutical Excipient Albumin Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Pharmaceutical Excipient Albumin Sales Quantity (2021-2032)
- 1.5.3 Global Pharmaceutical Excipient Albumin Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 CSL
- 2.1.1 CSL Details
- 2.1.2 CSL Major Business
- 2.1.3 CSL Pharmaceutical Excipient Albumin Product and Services
- 2.1.4 CSL Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 CSL Recent Developments/Updates
- 2.2 Grifols
- 2.2.1 Grifols Details
- 2.2.2 Grifols Major Business
- 2.2.3 Grifols Pharmaceutical Excipient Albumin Product and Services
- 2.2.4 Grifols Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Grifols Recent Developments/Updates
- 2.3 Takeda
- 2.3.1 Takeda Details
- 2.3.2 Takeda Major Business
- 2.3.3 Takeda Pharmaceutical Excipient Albumin Product and Services
- 2.3.4 Takeda Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Takeda Recent Developments/Updates
- 2.4 Octapharma
- 2.4.1 Octapharma Details
- 2.4.2 Octapharma Major Business
- 2.4.3 Octapharma Pharmaceutical Excipient Albumin Product and Services
- 2.4.4 Octapharma Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Octapharma Recent Developments/Updates
- 2.5 Hualan Bio
- 2.5.1 Hualan Bio Details
- 2.5.2 Hualan Bio Major Business
- 2.5.3 Hualan Bio Pharmaceutical Excipient Albumin Product and Services
- 2.5.4 Hualan Bio Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Hualan Bio Recent Developments/Updates
- 2.6 CBPO
- 2.6.1 CBPO Details
- 2.6.2 CBPO Major Business
- 2.6.3 CBPO Pharmaceutical Excipient Albumin Product and Services
- 2.6.4 CBPO Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 CBPO Recent Developments/Updates
- 2.7 Shanghai RAAS
- 2.7.1 Shanghai RAAS Details
- 2.7.2 Shanghai RAAS Major Business
- 2.7.3 Shanghai RAAS Pharmaceutical Excipient Albumin Product and Services
- 2.7.4 Shanghai RAAS Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Shanghai RAAS Recent Developments/Updates
- 2.8 Kedrion
- 2.8.1 Kedrion Details
- 2.8.2 Kedrion Major Business
- 2.8.3 Kedrion Pharmaceutical Excipient Albumin Product and Services
- 2.8.4 Kedrion Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Kedrion Recent Developments/Updates
- 2.9 LFB Group
- 2.9.1 LFB Group Details
- 2.9.2 LFB Group Major Business
- 2.9.3 LFB Group Pharmaceutical Excipient Albumin Product and Services
- 2.9.4 LFB Group Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 LFB Group Recent Developments/Updates
- 2.10 Albumedix
- 2.10.1 Albumedix Details
- 2.10.2 Albumedix Major Business
- 2.10.3 Albumedix Pharmaceutical Excipient Albumin Product and Services
- 2.10.4 Albumedix Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Albumedix Recent Developments/Updates
- 2.11 Biotest
- 2.11.1 Biotest Details
- 2.11.2 Biotest Major Business
- 2.11.3 Biotest Pharmaceutical Excipient Albumin Product and Services
- 2.11.4 Biotest Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Biotest Recent Developments/Updates
- 2.12 Merck
- 2.12.1 Merck Details
- 2.12.2 Merck Major Business
- 2.12.3 Merck Pharmaceutical Excipient Albumin Product and Services
- 2.12.4 Merck Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Merck Recent Developments/Updates
- 2.13 Ventria (InVitria)
- 2.13.1 Ventria (InVitria) Details
- 2.13.2 Ventria (InVitria) Major Business
- 2.13.3 Ventria (InVitria) Pharmaceutical Excipient Albumin Product and Services
- 2.13.4 Ventria (InVitria) Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Ventria (InVitria) Recent Developments/Updates
- 2.14 HiMedia
- 2.14.1 HiMedia Details
- 2.14.2 HiMedia Major Business
- 2.14.3 HiMedia Pharmaceutical Excipient Albumin Product and Services
- 2.14.4 HiMedia Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 HiMedia Recent Developments/Updates
3 Competitive Environment: Pharmaceutical Excipient Albumin by Manufacturer
- 3.1 Global Pharmaceutical Excipient Albumin Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Pharmaceutical Excipient Albumin Revenue by Manufacturer (2021-2026)
- 3.3 Global Pharmaceutical Excipient Albumin Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Pharmaceutical Excipient Albumin by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Pharmaceutical Excipient Albumin Manufacturer Market Share in 2025
- 3.4.3 Top 6 Pharmaceutical Excipient Albumin Manufacturer Market Share in 2025
- 3.5 Pharmaceutical Excipient Albumin Market: Overall Company Footprint Analysis
- 3.5.1 Pharmaceutical Excipient Albumin Market: Region Footprint
- 3.5.2 Pharmaceutical Excipient Albumin Market: Company Product Type Footprint
- 3.5.3 Pharmaceutical Excipient Albumin Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Pharmaceutical Excipient Albumin Market Size by Region
- 4.1.1 Global Pharmaceutical Excipient Albumin Sales Quantity by Region (2021-2032)
- 4.1.2 Global Pharmaceutical Excipient Albumin Consumption Value by Region (2021-2032)
- 4.1.3 Global Pharmaceutical Excipient Albumin Average Price by Region (2021-2032)
- 4.2 North America Pharmaceutical Excipient Albumin Consumption Value (2021-2032)
- 4.3 Europe Pharmaceutical Excipient Albumin Consumption Value (2021-2032)
- 4.4 Asia-Pacific Pharmaceutical Excipient Albumin Consumption Value (2021-2032)
- 4.5 South America Pharmaceutical Excipient Albumin Consumption Value (2021-2032)
- 4.6 Middle East & Africa Pharmaceutical Excipient Albumin Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Pharmaceutical Excipient Albumin Sales Quantity by Type (2021-2032)
- 5.2 Global Pharmaceutical Excipient Albumin Consumption Value by Type (2021-2032)
- 5.3 Global Pharmaceutical Excipient Albumin Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Pharmaceutical Excipient Albumin Sales Quantity by Application (2021-2032)
- 6.2 Global Pharmaceutical Excipient Albumin Consumption Value by Application (2021-2032)
- 6.3 Global Pharmaceutical Excipient Albumin Average Price by Application (2021-2032)
7 North America
- 7.1 North America Pharmaceutical Excipient Albumin Sales Quantity by Type (2021-2032)
- 7.2 North America Pharmaceutical Excipient Albumin Sales Quantity by Application (2021-2032)
- 7.3 North America Pharmaceutical Excipient Albumin Market Size by Country
- 7.3.1 North America Pharmaceutical Excipient Albumin Sales Quantity by Country (2021-2032)
- 7.3.2 North America Pharmaceutical Excipient Albumin Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Pharmaceutical Excipient Albumin Sales Quantity by Type (2021-2032)
- 8.2 Europe Pharmaceutical Excipient Albumin Sales Quantity by Application (2021-2032)
- 8.3 Europe Pharmaceutical Excipient Albumin Market Size by Country
- 8.3.1 Europe Pharmaceutical Excipient Albumin Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Pharmaceutical Excipient Albumin Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Pharmaceutical Excipient Albumin Market Size by Region
- 9.3.1 Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Pharmaceutical Excipient Albumin Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Pharmaceutical Excipient Albumin Sales Quantity by Type (2021-2032)
- 10.2 South America Pharmaceutical Excipient Albumin Sales Quantity by Application (2021-2032)
- 10.3 South America Pharmaceutical Excipient Albumin Market Size by Country
- 10.3.1 South America Pharmaceutical Excipient Albumin Sales Quantity by Country (2021-2032)
- 10.3.2 South America Pharmaceutical Excipient Albumin Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Pharmaceutical Excipient Albumin Market Size by Country
- 11.3.1 Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Pharmaceutical Excipient Albumin Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Pharmaceutical Excipient Albumin Market Drivers
- 12.2 Pharmaceutical Excipient Albumin Market Restraints
- 12.3 Pharmaceutical Excipient Albumin Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Pharmaceutical Excipient Albumin and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Pharmaceutical Excipient Albumin
- 13.3 Pharmaceutical Excipient Albumin Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Pharmaceutical Excipient Albumin Typical Distributors
- 14.3 Pharmaceutical Excipient Albumin Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Pharmaceutical Excipient Albumin. Industry analysis & Market Report on Pharmaceutical Excipient Albumin is a syndicated market report, published as Global Pharmaceutical Excipient Albumin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pharmaceutical Excipient Albumin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
